Scientific Advisory Board

The Scientific Advisory Board consists of leading international experts and is tasked with providing early assessments of market and technology developments that could impact ProbGen’s growth and positioning in the Life Sciences and Molecular Diagnostics sectors.
Sanjeev Kr. Chauhan - Founder & CEO of Probgen Biotech India Pvt. Ltd. A Clinical Diagnostic company that focuses on developing innovative solutions in the areas Clinical Diagnostics,Cancer,Next Generation Of Sequencing, biotechnology, genetic research, and diagnostics. Probgen Biotech India Pvt Ltd. is a clinical diagnostics kit manufacturer that specializes in developing and manufacturing innovative diagnostic products used in medical and healthcare applications. These diagnostic kits are typically designed to detect various diseases, conditions, and abnormalities through advanced technologies and biotechnology methods. While I don’t have detailed, up-to-date information on all the specific products manufactured by Probgen, here's an overview of what a clinical diagnostics kit manufacturer like them typically offers: 1. Professional Background: • As the Founder and CEO of Probgen Biotech, Sanjeev Kr. Chauhan has played a significant role in shaping the company’s direction, strategy, and operations. His leadership has likely been focused on driving innovation in the Clinical Diagnostic sector, particularly in Clinical Genomics,Cancer,NGS diagnostics, and related areas. 2. Expertise & Leadership: • With a solid background in biotechnology and business management, Chauhan has combined scientific expertise with entrepreneurial vision. His leadership at Probgen Biotech has likely contributed to advancements in biotechnology applications, focusing on providing high-quality diagnostic tools and services. 3. Company's Focus: • Probgen Biotech India Pvt.Ltd. focuses on offering cutting-edge technology products and services. These could include genetic testing, Clinical diagnostics,Cancer,Next Generation of Sequencing and other services that cater to medical, agricultural, and environmental needs. • The company's mission likely revolves around innovation, high-quality research, and offering advanced diagnostic tools to improve human health, agricultural productivity, and environmental sustainability. 4. Educational and Professional Qualifications: • He is graduated in biotechnology from Punjab University Chandigarh, Master In Business Administration and Biotechnology Management from Amity University Noida (UP) 5. Achievements and Contributions: • Chauhan’s leadership and the growth of Probgen Biotech would be marked by milestones such as product innovations, successful research and development projects, partnerships with other companies, and significant contributions to the biotechnology field. 6. Industry Recognition: • As a founder and CEO, Sanjeev Kr. Chauhan might also be recognized within the Clinical Diagnostic,Cancer,Forensic,Next Generation of Sequencing industry for his contributions to advancing scientific research and for driving the development of clinical diagnostics products that meet global standards. 7. Vision for the Future: • Chauhan’s vision for the company would likely focus on expanding Probgen Biotech’s reach in the biotechnology and diagnostic sectors, exploring new markets, and continuing to contribute to the healthcare Sectors Clinical Diagnostics Kits Manufactured by Probgen Biotech India Pvt. Ltd. 1. Product Types: • In Vitro Diagnostic Kits (IVDs): These diagnostic kits are used for detecting and diagnosing various diseases and conditions outside of the human body (in vitro). They are commonly used in clinical laboratories and hospitals to test blood, urine, saliva, or other biological samples. • Genetic Testing Kits: Probgen Biotech may offer diagnostic kits for genetic testing, which are essential for identifying inherited conditions, genetic disorders, and predispositions to certain diseases like cancer, heart disease, etc. • PCR (Polymerase Chain Reaction) Kits: PCR kits are a standard tool in molecular diagnostics. They help amplify small amounts of DNA or RNA to detect infectious diseases, genetic mutations, and various pathogens. • Serology Test Kits: These kits test blood serum for the presence of antibodies or antigens. They are often used to detect infections, allergies, autoimmune diseases, and to screen for viral or bacterial infections. • Cancer Screening Kits: Some diagnostic manufacturers produce kits specifically for cancer screening, detecting biomarkers associated with specific types of cancers, such as prostate, breast, or lung cancer. • Point-of-Care (POC) Testing Kits: These are portable diagnostic kits that provide immediate results at the site of patient care, often used in emergency settings, rural areas, or for rapid disease detection. 2. Technologies Used: • Molecular Diagnostics: Utilization of advanced molecular biology techniques (like PCR, RT-PCR, NGS or CRISPR-based technologies) for accurate diagnosis. • Immunoassays: Techniques like ELISA (Enzyme-Linked Immunosorbent Assay) are commonly used in diagnostic kits for detecting antigens or antibodies in patient samples. • Lateral Flow Assays: These tests are often used in rapid diagnostic kits (e.g., pregnancy tests or COVID-19 antigen tests), where the results are visually interpreted without the need for complex laboratory equipment. • Biochemical Reagents: Reagents that help in the chemical analysis of biological samples, often included in diagnostic kits for specific tests. 3. Quality and Compliance: • Clinical diagnostic kit manufacturers, especially those in India like Probgen Biotech, need to adhere to strict industry standards, ensuring that their products are safe, effective, and reliable. • These products typically undergo certifications such as ISO 13485 (for medical device manufacturing), CDSCO,CE certification (for European Union markets), and SFDA(SAUDI Food and drug administration)may also follow FDA or other regulatory standards for markets like the United States. 4. Applications: • Hospitals and Clinics: Diagnostic kits used in routine screenings, disease diagnostics, and pre-surgical assessments. • Research Institutions: For genetic research, biomarker identification, and clinical trials. • Laboratories: For disease testing, blood chemistry analysis, and other diagnostics. • Public Health and Disease Control: These kits play a critical role in epidemiological studies, vaccination programs, and monitoring public health conditions. 5. Focus Areas: • Infectious diseases (e.g., tuberculosis, malaria, HIV, hepatitis) • Cancer diagnostics (early detection of biomarkers) • Genetic disorders (screening for inherited genetic mutations) • Cardiovascular disease risk assessment • Endocrine and metabolic disorders (e.g., diabetes, thyroid) Company Overview: Probgen Biotech India Pvt. Ltd. Probgen Biotech India Pvt. Ltd. is likely committed to providing high-quality and innovative diagnostic solutions aimed at improving healthcare outcomes. By offering products that are at the cutting edge of biotechnology, they contribute significantly to the diagnostics industry in India and potentially other global markets. Their diagnostic kits are likely aimed at precision diagnostics, providing accurate, reliable, and timely results for clinicians, healthcare professionals, and patients. Our Tagline is we are “ One step Ahead”. If you are looking for specific product offerings or more technical details, it would be best to visit Probgen Biotech India Pvt. Ltd.'s official website or contact them directly for their product catalogue and any certifications they might hold.

Sanjeev K Chauhan

Founder,Chairman

Dr.Arvind Chaudhry

Director,Global Head R&D,Chair Scientific Advisory Board

 

Dr.KT Singh

Independent Director,Scientific Advisory Board

Dr.PK Sinha

Independent Director,Scientific Advisory Board

Dr.TN Shah

Independent Director,Scientific Advisory Board

Dr.Sk Partha

Independent Director,Scientific Advisory Board

Dr.B Thakur

Independent Director,Scientific Advisory Board